Biotech

Biotech & Healthcare

Biotech Healthcare Essentials publishes only the best Biotech news and links, carefully hand-picked and curated by top biotech experts.

Top news of the week: 11.09.2023.

Health care
Disease
United States
Biotechnology
Pharmaceutical drug
New York

@WSJ Health shared
On Sep 11, 2023
Fake tweet - https://thediplomat.com/2023/09/are-chinas-healthcare-and-biopharma-sectors-really-open-for-investment/
Open
Are China’s Healthcare and Biopharma Sectors Really Open for Investment?

Are China’s Healthcare and Biopharma Sectors Really Open for Investment?

To attract foreign investment, the Chinese healthcare and biopharma sectors are more open for business than ever – or at least they claim to be. But challenges exist beneath the surface.

@WSJ Health shared
On Sep 5, 2023
Fake tweet - https://taylorpamela77.wixsite.com/my-site/post/new-zealand-medsafe-medical-fraud-by-marketing-a-biosynthetic-bioweapon
Open
NEW ZEALAND MEDSAFE MEDICAL FRAUD BY MARKETING A BIOSYNTHETIC BIOWEAPON

NEW ZEALAND MEDSAFE MEDICAL FRAUD BY MARKETING A BIOSYNTHETIC BIOWEAPON

#COVID19 #vaccine #MEDSAFE #NEWZEALAND MEDSAFE COMITTED MEDICAL FRAUD WHEN THEY KNOWINGLY AND INTENTIONALLY MISREPRESENTED A BIOSYNTHETIC PATHOGEN AS A VACCINE, THESE BIOLOGICAL, CHEMICAL, ...

@WSJ Health shared
On Sep 9, 2023
Fake tweet - https://www.nbcnews.com/health/health-news/-counter-decongestant-really-work-fda-panel-re-evaluate-phenylephrine-rcna103868
Open
Does this over-the-counter decongestant really work? FDA panel to re-evaluate phenylephrine

Does this over-the-counter decongestant really work? FDA panel to re-evaluate phenylephrine

For years, doctors and pharmacists have said the oral decongestant phenylephrine, found in drugs including Sudafed PE, isn't actually effective.

@WSJ Health shared
On Sep 7, 2023
Fake tweet - https://www.nbcnews.com/health/health-news/fda-green-light-new-covid-boosters-early-friday-rcna103379
Open
FDA could greenlight new Covid boosters as early as Friday

FDA could greenlight new Covid boosters as early as Friday

The shots could become available next week, after the Centers for Disease Control and Prevention also signs off.

@WSJ Health shared
On Sep 7, 2023
Fake tweet - https://www.timesofisrael.com/pitango-pulls-in-175-million-to-invest-in-israeli-health-tech-startups/
Open
Pitango pulls in $175 million to invest in Israeli health tech startups

Pitango pulls in $175 million to invest in Israeli health tech startups

Herzliya-based venture capital firm launches second fund to back locally founded startups in areas of digital health, medical devices, diagnostics, and life sciences

@WSJ Health shared
On Sep 7, 2023
Fake tweet - https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0011522
Open
Weekly primaquine for radical cure of patients with Plasmodium vivax malaria and glucose-6-phosphate dehydrogenase deficiency

Weekly primaquine for radical cure of patients with Plasmodium vivax malaria and glucose-6-phosphate dehydrogenase deficiency

Author summary Fifty patients with P. vivax malaria and glucose-6-phosphate dehydrogenase (G6PD) deficiency were given the WHO-recommended, primaquine regimen of 0.75 mg/kg body weight once ...

@WSJ Health shared
On Sep 9, 2023
Fake tweet - https://www.forbes.com/sites/shimonshkury/2023/09/08/beyond-class-a-winning-investment-strategies-in-the-new-york-city-office-market/
Open
Beyond Class A: Winning Investment Strategies In The New York City Office Market

Beyond Class A: Winning Investment Strategies In The New York City Office Market

Challenges in the office market are forcing owners/developers to see buildings through a new lens, which could lead to conversions to life sciences or residential use.

@WSJ Health shared
On Sep 11, 2023
Fake tweet - https://www.bostonherald.com/2023/09/10/bio-charged-vc-funding-employment-continues-climb-in-bay-states-biotech-sector/
Open
Bio-charged: VC funding, employment continues climb in Bay State’s biotech sector

Bio-charged: VC funding, employment continues climb in Bay State’s biotech sector

A MassBio report of the life sciences industry reveals that Massachusetts’ increased research and development workforce and venture capital funding underscore the state’s vitality in ...